Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

Conclusion IngMebs were cost-effective AK treatments in Finland. Funding LEO Pharma.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research